Literature DB >> 3955026

Effect of nucleotide on the binding of N,N'-p-phenylenedimaleimide-modified S-1 to unregulated and regulated actin.

L E Greene, J M Chalovich, E Eisenberg.   

Abstract

In our previous study [Chalovich, J. M., Greene, L. E., & Eisenberg, E. (1983) Proc. Natl. Acad. Sci. U.S.A. 80, 4909-4913], myosin subfragment 1 that was modified by having its two reactive thiol groups cross-linked by N,N'-p-phenylenedimaleimide (pPDM) was found to resemble the myosin subfragment 1-adenosine 5'-triphosphate (S-1.ATP) complex in its interaction with actin. In the present study, we examined the effect of actin on adenosine 5'-diphosphate (ADP) trapped at the active site of pPDM.S-1. Our results indicate first that, in the presence of actin, ADP is no longer trapped at the active site but exchanges rapidly with free nucleotide. Different pPDM.S-1.nucleotide complexes were then formed by exchanging nucleotide into the active site of pPDM.S-1 in the presence of actin. The binding of pPDM.S-1.ATP or pPDM.S-1.PPi to actin is virtually identical with that of unmodified S-1 in the presence of ATP. Specifically, at mu = 18 mM, 25 degrees C, pPDM.S-1.ATP or pPDM.S-1.PPi binds to unregulated actin with the same affinity as does S-1.ATP, and this binding does not appear to be affected by troponin-tropomyosin. On the other hand, pPDM.S-1.ADP and pPDM.S-1 with no bound nucleotide both show a small, but significant, difference between their binding to actin and the binding of S-1.ATP; pPDM.S-1 and pPDM.S-1.ADP both bind about 2- to 3-fold more strongly to unregulated actin than does S-1.ATP.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3955026     DOI: 10.1021/bi00351a030

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Three distinct actin-attached structural states of myosin in muscle fibers.

Authors:  Ryan N Mello; David D Thomas
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

2.  Crystallographic findings on the internally uncoupled and near-rigor states of myosin: further insights into the mechanics of the motor.

Authors:  D M Himmel; S Gourinath; L Reshetnikova; Y Shen; A G Szent-Györgyi; C Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-24       Impact factor: 11.205

3.  Structural dynamics of the actomyosin complex probed by a bifunctional spin label that cross-links SH1 and SH2.

Authors:  Andrew R Thompson; Nariman Naber; Clyde Wilson; Roger Cooke; David D Thomas
Journal:  Biophys J       Date:  2008-09-19       Impact factor: 4.033

4.  Behavior of N-phenylmaleimide-reacted muscle fibers in magnesium-free rigor solution.

Authors:  S Xu; L C Yu; M Schoenberg
Journal:  Biophys J       Date:  1998-03       Impact factor: 4.033

5.  Regulation of actomyosin ATPase activity by troponin-tropomyosin: effect of the binding of the myosin subfragment 1 (S-1).ATP complex.

Authors:  L E Greene; D L Williams; E Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  A model of force production that explains the lag between crossbridge attachment and force after electrical stimulation of striated muscle fibers.

Authors:  M A Bagni; G Cecchi; M Schoenberg
Journal:  Biophys J       Date:  1988-12       Impact factor: 4.033

7.  Troponin-tropomyosin: an allosteric switch or a steric blocker?

Authors:  Andrea M Resetar; Jacqueline M Stephens; Joseph M Chalovich
Journal:  Biophys J       Date:  2002-08       Impact factor: 4.033

8.  Formation of ATP-insensitive weakly-binding crossbridges in single rabbit psoas fibers by treatment with phenylmaleimide or para-phenylenedimaleimide.

Authors:  V A Barnett; A Ehrlich; M Schoenberg
Journal:  Biophys J       Date:  1992-02       Impact factor: 4.033

9.  Cross-linking myosin subfragment 1 Cys-697 and Cys-707 modifies ATP and actin binding site interactions.

Authors:  K Kirshenbaum; S Papp; S Highsmith
Journal:  Biophys J       Date:  1993-09       Impact factor: 4.033

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.